Ralph Venhaus

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Danila Valmori, Naira E. Souleimanian, Valeria Tosello et al. · Proceedings of the National Academy of Sciences · 2007 · 295 citations · Full text

Medicine, Immunology, Oncology +17

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Paul Sabbatini, Takemasa Tsuji, Luis Ferran et al. · Clinical Cancer Research · 2012 · 273 citations

Medicine, Immunology, Oncology +17

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant

Sylvia Adams, David O’Neill, Daisuke Nonaka et al. · The Journal of Immunology · 2008 · 245 citations · Full text

Medicine, Immunology, Oncology +17

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Patrick A. Ott, Richard D. Carvajal, Neeta Pandit‐Taskar et al. · Investigational New Drugs · 2012 · 146 citations · Full text

Medicine, Clinical Sciences, Oncology +14

Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

Theo Nicholaou, Lisa M. Ebert, Ian D. Davis et al. · Clinical Cancer Research · 2009 · 118 citations · Full text

Medicine, Immunology, Oncology +17